Cytogenetic and Genome Research
F-bodies as Y chromosome markers in mature human sperm heads: a quantitative approachBeatty R.A.ARC Unit of Animal Genetics, Department of Genetics, University of Edinburgh, Edinburgh
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Accepted: October 21, 1976
Published online: May 02, 2008
Issue release date: 1977
Number of Print Pages: 17
Number of Figures: 0
Number of Tables: 0
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Abstract
It is generally accepted that at least some Y chromosomes in human mature sperm heads are represented in preparations by fluorescent F-bodies. From data consisting solely of F-body scorings and the visually estimated size of sperm heads from normal donors, a quantitative model is developed which permits simultaneous estimation of six parameters representing biological factors (the proportions of ploidy classes and of their sex-chromosome complements) and biassing factors (not all Y chromosomes represented by F-bodies, not all F-bodies representing Y chromosomes, and error in scoring ploidy from visual size). The analysis is statistically adequate and succeeds in predicting a variety of independently validated phenomena. The work may be regarded as a contribution to the integration of qualitative and quantitative evidence in the study of F-bodies. In all, 21,700 one-headed spermatozoa from 12 donors were scored. A mean of 54 % spermatozoa lacking F-bodies was subject to a standard deviation between donors of 4.8, over and above binomial error. Analysis yielded the following estimates: 83.3 % of diploid spermatozoa are XY, the remainder XX and YY in assumed equal number (this information assists analysis of the origin of embryonic triploidy); 2.4 % of spermatozoa are diploid (this estimate does not compete in accuracy with direct estimates from DNA absorbance); only 83 % of Y chromosomes are represented by F-bodies; 7 % of haploid heads and 14 % of diploids contain one or more “adventitious bodies” indistinguishable from true F-bodies. The visually scored head sizes “Small” and “Medium” correspond approximately with haploidy and diploidy; nearly all haploids are scored as Small, and 72% of the Medium are diploid. F-bodies are not thought at present to give a useful basis for estimating the presumably low incidence of sex-chromosome aneuploidy and nondisjunction. No such estimate has been attempted. The problem is overshadowed by not fully understood complicating factors of greater magnitude, which now appear to be a major subject of enquiry. Some implications and possible future developments are discussed.
© 1977 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Accepted: October 21, 1976
Published online: May 02, 2008
Issue release date: 1977
Number of Print Pages: 17
Number of Figures: 0
Number of Tables: 0
ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)
For additional information: https://www.karger.com/CGR
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
